OPK vs. BTAI

In the year-to-date period, OPK achieves a -15.65% return, which is significantly higher than BTAI's -74.42% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for OPKO Health, Inc. (OPK) and BioXcel Therapeutics, Inc. (BTAI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current OPK Sharpe Ratio is -0.04, which is higher than the BTAI Sharpe Ratio of -0.68. The chart below compares the historical Sharpe Ratios of OPK and BTAI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither OPK nor BTAI has paid dividends to shareholders.

The maximum OPK drawdown since its inception was -98.17%, roughly equal to the maximum BTAI drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for OPK and BTAI. For additional features, visit the drawdowns tool.

The current volatility for OPKO Health, Inc. (OPK) is 14.54%, while BioXcel Therapeutics, Inc. (BTAI) has a volatility of 23.81%. This indicates that OPK experiences smaller price fluctuations and is considered to be less risky than BTAI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between OPKO Health, Inc. and BioXcel Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.